CREB3L2 and neoplasm: The tumour-specific FUS-CREB3L2 fusion gene can be detected using a reverse-transcription polymerase chain reaction (RT-PCR) using formalin-fixed paraffin-embedded tissue [11,18] (the sensitivity using DNA-based PCR is reported to be lower [18]), and by fluorescence in situ hybridisation (FISH).